EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 68 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $120,658,000 | +2.5% | 1,454,778 | -2.0% | 0.10% | 0.0% |
| Q4 2016 | $117,765,000 | +7.8% | 1,484,241 | -4.9% | 0.10% | +7.6% |
| Q3 2016 | $109,282,000 | +89.1% | 1,561,176 | +4.8% | 0.09% | +87.8% |
| Q2 2016 | $57,805,000 | -1.4% | 1,490,229 | +2.9% | 0.05% | -3.9% |
| Q1 2016 | $58,627,000 | -46.2% | 1,447,539 | +17.8% | 0.05% | -45.2% |
| Q4 2015 | $108,944,000 | -4.8% | 1,228,641 | -20.6% | 0.09% | +82.4% |
| Q3 2015 | $114,484,000 | +80.3% | 1,546,444 | +96.9% | 0.05% | -1.9% |
| Q2 2015 | $63,514,000 | +92.7% | 785,480 | -0.2% | 0.05% | +92.6% |
| Q1 2015 | $32,963,000 | – | 786,902 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 112,666 | $1,777 | 0.65% |
| Smith, Graham & Co., Investment Advisors, LP | 273,099 | $4,306,771 | 0.54% |
| BRANDES INVESTMENT PARTNERS, LP | 1,134,363 | $17,888,904 | 0.35% |
| TANG CAPITAL MANAGEMENT LLC | 118,857 | $1,874,375 | 0.26% |
| Virtus Investment Advisers, Inc. | 20,867 | $329,073 | 0.22% |
| DENALI ADVISORS LLC | 32,300 | $509,371 | 0.18% |
| Nebula Research & Development LLC | 11,473 | $180,929 | 0.10% |
| SCOUT INVESTMENTS, INC. | 131,192 | $1,995,430 | 0.05% |
| XTX Topco Ltd | 15,050 | $237,339 | 0.04% |
| PDT Partners, LLC | 19,745 | $311,379 | 0.04% |